Hennion & Walsh Asset Management, Inc. Moderna, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 3,110 shares of MRNA stock, worth $217,264. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,110
Previous 3,193
2.6%
Holding current value
$217,264
Previous $340,000
8.53%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding MRNA
# of Institutions
1,112Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$3.04 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.76 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.79 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$1.05 Billion0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$505 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $27.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...